Mar 16 2015
NEW YORK, NY
Traverse Biosciences, founded by Joseph Scaduto - one of the Center for Biotechnology's first BioEntrepreneurs-in-Residence, annou
Learn MoreGaurav Lalwani, PhD, Biomedical Engineering department at Stony brook University and Center for Biotechnology Fundamentals Program
Learn MoreA new mathematical model that uses drug-target kinetics to predict how drugs work in vivo may provide a foundation to improve drug
Learn MoreThe Redesignation brings $10 million in funding to drive innovation, company formation, and economic growth. The Center for Biotechnology (CFB) has announced its re-designated as a Center for Advanced Technology (CAT) by Empire State Development‘s Division of Science, Technology and …
Learn MoreEnvisagenics, supported by the Center for Biotechnology at Stony Brook University, is a pioneering biotech company that has been applying AI to drug target discovery for over a decade. In drug development, targets are molecular structures (often proteins) where drugs …
Learn MoreFunds received by Stony Brook University will be used in part to reimagine its existing Department of Technology and Society in the College of Engineering and Applied Sciences (CEAS).
Learn More